Takeda lung cancer drug gets European panel nod

Takeda Pharmaceutical Co's lung cancer drug received the recommendation of a European Union panel on Friday, more than a year after it won regulatory approval to be sold in the United States.

from Reuters: Health https://ift.tt/2xrP9qc